These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 9120000)

  • 1. Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.
    Miao HQ; Ornitz DM; Aingorn E; Ben-Sasson SA; Vlodavsky I
    J Clin Invest; 1997 Apr; 99(7):1565-75. PubMed ID: 9120000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.
    Liekens S; Leali D; Neyts J; Esnouf R; Rusnati M; Dell'Era P; Maudgal PC; De Clercq E; Presta M
    Mol Pharmacol; 1999 Jul; 56(1):204-13. PubMed ID: 10385702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative activity to glomerular mesangial cells and receptor binding of a heparin-mimicking polyaromatic anionic compound.
    Katz A; Vlodavsky I; Davies M; Miao HQ; Ben-Sasson SA; Darmon D; Hurwitz H; Borgel H; Benezra M
    J Am Soc Nephrol; 1997 Nov; 8(11):1688-97. PubMed ID: 9355071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-2 can mediate cell attachment by linking receptors and heparan sulfate proteoglycans on neighboring cells.
    Richard C; Liuzzo JP; Moscatelli D
    J Biol Chem; 1995 Oct; 270(41):24188-96. PubMed ID: 7592623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall.
    Medalion B; Merin G; Aingorn H; Miao HQ; Nagler A; Elami A; Ishai-Michaeli R; Vlodavsky I
    Circulation; 1997 Apr; 95(7):1853-62. PubMed ID: 9107173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound.
    Schmidt A; Vlodavsky I; Völker W; Buddecke E
    Atherosclerosis; 1999 Dec; 147(2):387-97. PubMed ID: 10559525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin.
    Lundin L; Rönnstrand L; Cross M; Hellberg C; Lindahl U; Claesson-Welsh L
    Exp Cell Res; 2003 Jul; 287(1):190-8. PubMed ID: 12799194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds.
    Benezra M; Ben-Sasson SA; Regan J; Chang M; Bar-Shavit R; Vlodavsky I
    Arterioscler Thromb; 1994 Dec; 14(12):1992-9. PubMed ID: 7981190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly.
    Ibrahimi OA; Zhang F; Hrstka SC; Mohammadi M; Linhardt RJ
    Biochemistry; 2004 Apr; 43(16):4724-30. PubMed ID: 15096041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2.
    Hagedorn M; Zilberberg L; Lozano RM; Cuevas P; Canron X; Redondo-Horcajo M; Gimenez-Gallego G; Bikfalvi A
    FASEB J; 2001 Mar; 15(3):550-2. PubMed ID: 11259363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A.
    Motamed K; Blake DJ; Angello JC; Allen BL; Rapraeger AC; Hauschka SD; Sage EH
    J Cell Biochem; 2003 Oct; 90(2):408-23. PubMed ID: 14505356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic fibroblast growth factor (FGF-1) and FGF receptor 1 signaling in human Y79 retinoblastoma.
    Siffroi-Fernandez S; Cinaroglu A; Fuhrmann-Panfalone V; Normand G; Bugra K; Sahel J; Hicks D
    Arch Ophthalmol; 2005 Mar; 123(3):368-76. PubMed ID: 15767480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
    Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
    J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase.
    Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ
    J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.
    Moscatelli D
    J Biol Chem; 1992 Dec; 267(36):25803-9. PubMed ID: 1464594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1.
    Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL
    Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1.
    Lam K; Rao VS; Qasba PK
    J Biomol Struct Dyn; 1998 Jun; 15(6):1009-27. PubMed ID: 9669548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.